Research and practice in thrombosis and haemostasis

Keyphrases

Publications

volume 8, number 5, 2024

Simon Jaouen, Fanny Mingant, Brigitte Pan-Petesch, Eric Lippert, Emmanuelle Jeanpierre, Hubert Galinat
A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Gwenaëlle Mahieu, Anne-Laure Sennesael, Lionel Pochet, Vincent Haufroid, Françoise Van Bambeke, Anne Spinewine, Laure Elens
In vitro assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Simon Jaouen, Fanny Mingant, Brigitte Pan-Petesch, Eric Lippert, Emmanuelle Jeanpierre, Hubert Galinat
A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Yuyang Sun, Jun Deng, Yajie Ding, Shanshan Luo, Si Li, Yunlong Guan, Xi Cao, Xingjie Hao, Yu Hu
Serum albumin, genetic susceptibility, and risk of venous thromboembolism. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Katerina Pavenski, Marie Scully, Paul Coppo, Spero Cataland, Paul Knöbl, Flora Peyvandi, Johanna A Kremer Hovinga, Javier de la Rubia, Umer Khan, Ana Paula Marques, Sriya Gunawardena
Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpura. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Saengrawee Arunothai, Yuda Sutherasan, Tanapong Panpikoon, Pongdhep Theerawit, Pantep Angchaisuksiri, Kochawan Boonyawat
Low incidence of deep vein thrombosis in critically ill medical patients in Thais: a prospective study. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Yuyang Sun, Jun Deng, Yajie Ding, Shanshan Luo, Si Li, Yunlong Guan, Xi Cao, Xingjie Hao, Yu Hu
Serum albumin, genetic susceptibility, and risk of venous thromboembolism. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Mansour Gergi, Katherine Wilkinson, Timothy B Plante, Neil A Zakai
Ascertaining accurate exposure to aspirin and other antithrombotic medications using structured electronic health record data. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Azusa Nagao, Satoko Orita, Katsuyuki Fukutake, Hideyuki Takedani
Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Azusa Nagao, Satoko Orita, Katsuyuki Fukutake, Hideyuki Takedani
Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Shinya Yamada, Kazuya Sakai, Masayuki Kubo, Hirokazu Okumura, Hidesaku Asakura, Toshihiro Miyamoto, Masanori Matsumoto
Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Zhenzhen Zhao, Yixin Cheng, Yaqiong Zhang, Meinan Peng, Yue Han, Depei Wu, Aizhen Yang, Yi Wu
Transmembrane thiol isomerase TMX1 counterbalances the effect of ERp46 to inhibit platelet activation and integrin αIIbβ3 function. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Gwenaëlle Mahieu, Anne-Laure Sennesael, Lionel Pochet, Vincent Haufroid, Françoise Van Bambeke, Anne Spinewine, Laure Elens
In vitro assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Ami Vadgama, James Boot, Nicola Dark, Harriet E Allan, Charles A Mein, Paul C Armstrong, Timothy D Warner
Multiparameter phenotyping of platelets and characterization of the effects of agonists using machine learning. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Maria Rita Cozzi, Fabio Del Ben, Chiara Corso, Agostino Steffan
A comparative study of anti-ADAMTS-13 antibody dynamics in immune-mediated thrombotic thrombocytopenic purpura. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Yutaka Umemura, Naoki Okada, Hiroshi Ogura, Jun Oda, Satoshi Fujimi
A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Katerina Pavenski, Marie Scully, Paul Coppo, Spero Cataland, Paul Knöbl, Flora Peyvandi, Johanna A Kremer Hovinga, Javier de la Rubia, Umer Khan, Ana Paula Marques, Sriya Gunawardena
Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpura. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Riccardo M Fumagalli, Davide Voci, Behnood Bikdeli, Roland Bingisser, Giuseppe Colucci, Gabor Forgo, Teresa Gerardi, Bernhard Gerber, Alexandru Grigorean, Frederikus A Klok, Marc Righini, Helia Robert-Ebadi, Stefan Stortecky, Silvia Ulrich, Simon Wolf, Dörte Wyss, Lukas Hobohm, Nils Kucher, Stefano Barco, null null
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Mansour Gergi, Katherine Wilkinson, Timothy B Plante, Neil A Zakai
Ascertaining accurate exposure to aspirin and other antithrombotic medications using structured electronic health record data. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Maria Rita Cozzi, Fabio Del Ben, Chiara Corso, Agostino Steffan
A comparative study of anti-ADAMTS-13 antibody dynamics in immune-mediated thrombotic thrombocytopenic purpura. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Mansour Gergi, Katherine Wilkinson, Timothy B Plante, Neil A Zakai
Ascertaining accurate exposure to aspirin and other antithrombotic medications using structured electronic health record data. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Saengrawee Arunothai, Yuda Sutherasan, Tanapong Panpikoon, Pongdhep Theerawit, Pantep Angchaisuksiri, Kochawan Boonyawat
Low incidence of deep vein thrombosis in critically ill medical patients in Thais: a prospective study. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Andrea Jimena Morales Arteaga, Carme Font, Cristhiam M Rojas Hernandez
Quality of life in oncological patients with venous thromboembolic disease. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Christian Qvigstad, Lars Q Sørensen, Geir E Tjønnfjord, Pål André Holme, null null
The association between unemployment and treatment among adults with hemophilia. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Andrea Jimena Morales Arteaga, Carme Font, Cristhiam M Rojas Hernandez
Quality of life in oncological patients with venous thromboembolic disease. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Yoshito Ogihara, Norikazu Yamada, Daisuke Izumi, Yuichi Sato, Toru Sato, Hitoshi Nakaya, Tatsuya Mori, Satoshi Ota, Midori Makino, Toru Ogura, Satoshi Tamaru, Yuki Nishimura, Takashi Tanigawa, Atsunobu Kasai, Masakatsu Nishikawa, Kaoru Dohi, null null
Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Michael Makris, Mouhamed Yazan Abou-Ismail
Navigating the inevitable: artificial intelligence and the future of scientific communication. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Yutaka Umemura, Naoki Okada, Hiroshi Ogura, Jun Oda, Satoshi Fujimi
A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Yoshito Ogihara, Norikazu Yamada, Daisuke Izumi, Yuichi Sato, Toru Sato, Hitoshi Nakaya, Tatsuya Mori, Satoshi Ota, Midori Makino, Toru Ogura, Satoshi Tamaru, Yuki Nishimura, Takashi Tanigawa, Atsunobu Kasai, Masakatsu Nishikawa, Kaoru Dohi, null null
Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Christian Qvigstad, Lars Q Sørensen, Geir E Tjønnfjord, Pål André Holme, null null
The association between unemployment and treatment among adults with hemophilia. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Nicoletta Riva, Lorna Muscat-Baron, Carine Vassallo, Walter Ageno, Amihai Rottenstreich, Nadine Sauvé, Waldemar E Wysokinski, Gary L Goldberg, Ophira Salomon, Nicos Labropoulos, Arthur Foulon, Mohammed AlSheef, Alex Gatt, Jean Calleja-Agius
Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies. Research and practice in thrombosis and haemostasis 8 (5) (2024)
Shirin Bakhtari, Flavien Vincent, Sophie Susen
Bleeding in valvular heart disease: is von Willebrand factor the culprit? Research and practice in thrombosis and haemostasis 8 (5) (2024)
Shirin Bakhtari, Flavien Vincent, Sophie Susen
Bleeding in valvular heart disease: is von Willebrand factor the culprit? Research and practice in thrombosis and haemostasis 8 (5) (2024)

volume 8, number 6, 2024

Michael Hardy, Emilie Catry, Marie Pouplard, Thomas Lecompte, François Mullier
Is lupus anticoagulant testing with dilute Russell's viper venom clotting times reliable in the presence of inflammation? Research and practice in thrombosis and haemostasis 8 (6) (2024)
Stefano Gitto, Claudia Fiorillo, Flavia Rita Argento, Eleonora Fini, Serena Borghi, Margherita Falcini, Davide Roccarina, Rosario La Delfa, Ludovica Lillo, Tommaso Zurli, Paolo Forte, Davide Ghinolfi, Paolo De Simone, Francesca Chiesi, Angelica Ingravallo, Francesco Vizzutti, Silvia Aspite, Giacomo Laffi, Erica Lynch, Stefania Petruccelli, Paola Carrai, Simona Palladino, Francesco Sofi, Laura Stefani, Amedeo Amedei, Simone Baldi, Arianna Toscano, Chloe Lau, Fabio Marra, Matteo Becatti
Oxidative stress-induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Julia S Gauer, Abigail Ajanel, Lutale M Kaselampao, Isabel Candir, Amanda D V MacCannell, Lee D Roberts, Robert A Campbell, Robert A S Ariëns
Plant-derived compounds normalize platelet bioenergetics and function in hyperglycemia. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Nicolas Gendron, Dominique Helley, Philippe Rousselot, Virginie Siguret, Pascale Gaussem, Chloé James, Lina Khider, Nadine Ajzenberg, Elodie Boissier, Nicolas Boissel, David M Smadja, Benjamin Planquette
Evaluation of hemostasis understanding in medical and pharmacy students from a Parisian university. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Nicholas L J Chornenki, Heather McPhaden, Erica A Peterson, Chieh Min Benjamin Lai, Agnes Y Y Lee
Dual direct oral anticoagulant therapy in challenging thrombosis: a case series. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Kefeng Shen, Ting Chen, Min Xiao
MYH9 -related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Ulla Derhaschnig, Nina Buchtele, Margarete M Steiner, Christa Drucker, Christa Firbas, Christian Schörgenhofer, Georg Gelbenegger, Franz König, Bernd Jilma, Katarina D Kovacevic Miljevic
Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisons. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Csaba Siffel, Abhinav Wadhwa, Vanita Tongbram, Margaret Katana Ogongo, Henrik Sliwka, Hanna T Gazda, Peter L Turecek
Comprehensive literature review of protein C concentrate use in patients with severe congenital protein C deficiency. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Maddie Stephen, Carolyne Elbaz, Hina Hanif, Katerina Pavenski, Jerry Teitel, Michelle Sholzberg
Cross-reacting antiporcine factor VIII inhibitors in patients with acquired hemophilia A. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Marie-Astrid van Dievoet, Karim Zouaoui Boudjeltia, Madeleine Rousseaux, Jonathan Douxfils, Ton Lisman, Xavier Stephenne
Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by 2 different plasma-based fibrinolysis assays. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Chen Li, Michael Malloy, Sara K Ture, Benjamin Nieves-Lopez, Florian Thibord, Andrew D Johnson, Craig N Morrell
G protein-coupled receptor kinase 5 regulates thrombin signaling in platelets. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Lize F D van Vulpen, F Nanne Croles, Roger E G Schutgens
Letter in response to Bounaix et al. "Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature". Research and practice in thrombosis and haemostasis 8 (6) (2024)
Tim A C de Vries, Roisin Bavalia, Gordon Chu, Helen Xiong, Kayleigh M van de Wiel, Hanne van Ballegooijen, Menno V Huisman, Martin E W Hemels, Saskia Middeldorp, Joris R de Groot
Prescription and switching patterns of direct oral anticoagulants in patients with atrial fibrillation. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Josepha C Sedzro, Stephanie A Smith, Alexander Scott, Yuqi Wang, Richard J Travers, Rachel Hemp, Chase N Morse, James H Morrissey
Antipolyphosphate monoclonal antibodies derived from autoimmune mice. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Bilgimol Chumappumkal Joseph, Tro Sekayan, Nicca Falah, Richard F W Barnes, Veronica Flood, Juan A De Pablo-Moreno, Annette von Drygalski
Traumatic bleeding and mortality in mice are intensified by iron deficiency anemia and can be rescued with tranexamic acid. Research and practice in thrombosis and haemostasis 8 (6) (2024)
S F B van der Horst, Y de Jong, N van Rein, J W Jukema, M Palmen, E Janssen, E F Bonneville, F A Klok, M V Huisman, L F Tops, P L den Exter
Erratum to 'Performance of Risk Scores in Predicting Major Bleeding in Left Ventricular Assist Device (LVAD) Recipients: a Comparative External Validation. '[Res Pract Thromb Haemost. 2024;8:e102437]. Research and practice in thrombosis and haemostasis 8 (6) (2024)
Rahman Ladak, Massimo Sementilli, Jillian Calandra, Alejandro Lazo-Langner, Deborah Siegal, Tzu-Fei Wang, Rong Luo, Andrea L Cervi
Physician practice patterns on the use of inferior vena cava filters in venous thromboembolism. Research and practice in thrombosis and haemostasis 8 (6) (2024)